Exercise Training as Therapy for Heart Failure Current Status and Future Directions

被引：129

作者：

Fleg, Jerome L. ^{[1
]}

Cooper, Lawton S. ^{[1
]}

Borlaug, Barry A. ^{[2
]}

Haykowsky, Mark J. ^{[3
]}

Kraus, William E. ^{[4
]}

Levine, Benjamin D. ^{[5
]}

Pfeffer, Marc A. ^{[6
]}

Pina, Ileana L. ^{[7
]}

Poole, David C. ^{[8
,9
]}

Reeves, Gordon R. ^{[10
]}

Whellan, David J. ^{[10
]}

Kitzman, Dalane W. ^{[11
,12
]}

机构：

[1] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA

[2] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA

[3] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada

[4] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA

[5] Univ Texas SW Med Ctr Dallas, Inst Exercise & Environm Med, Dallas, TX 75390 USA

[6] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

[7] Albert Einstein Coll Med, Div Cardiol, Bronx, NY 10467 USA

[8] Kansas State Univ, Dept Kinesiol, Manhattan, KS 66506 USA

[9] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA

[10] Thomas Jefferson Univ, Jefferson Med Coll, Div Cardiol, Philadelphia, PA 19107 USA

[11] Wake Forest Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC USA

[12] Wake Forest Sch Med, Dept Internal Med, Sect Geriatr, Winston Salem, NC USA

来源：

CIRCULATION-HEART FAILURE | 2015年 / 8卷 / 01期

关键词：

heart failure; therapy; PRESERVED EJECTION FRACTION; CARDIAC RESYNCHRONIZATION THERAPY; QUALITY-OF-LIFE; RANDOMIZED-TRIALS; PHYSICAL-ACTIVITY; REHABILITATION PROGRAM; OXYGEN-CONSUMPTION; SYSTOLIC FUNCTION; PROGNOSTIC VALUE; ELDERLY-PATIENTS;

D O I：

10.1161/CIRCHEARTFAILURE.113.001420

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：209 / 220

页数：12

共 50 条

[1] Current Studies and Future Directions of Exercise Therapy for Muscle Atrophy Induced by Heart Failure
Liu, Qi
Gao, Juan
Deng, Jiali
Xiao, Junjie
[J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
[2] Cell therapy for heart disease: current status and future directions
Kahlon, Arunpreet
Vaidya, Gaurang
Bolli, Roberto
[J]. MINERVA CARDIOANGIOLOGICA, 2018, 66 (03): : 273 - 291
[3] Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
Bharathi Upadhya
Mark J. Haykowsky
Dalane W. Kitzman
[J]. Heart Failure Reviews, 2018, 23 : 609 - 629
[4] Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
Upadhya, Bharathi
Haykowsky, Mark J.
Kitzman, Dalane W.
[J]. HEART FAILURE REVIEWS, 2018, 23 (05) : 609 - 629
[5] Thromboembolism and Antithrombotic Therapy in Patients With Heart Failure in Sinus Rhythm Current Status and Future Directions
Bettari, Luca
Fiuzat, Mona
Becker, Richard
Felker, G. Michael
Metra, Marco
O'Connor, Christopher M.
[J]. CIRCULATION-HEART FAILURE, 2011, 4 (03) : 361 - 368
[6] Endothelin receptor antagonists in heart failure - Current status and future directions
Ertl, G
Bauersachs, J
[J]. DRUGS, 2004, 64 (10) : 1029 - 1040
[7] Chronic Heart Failure Current Evidence, Challenges to Therapy, and Future Directions
Morrissey, Ryan P.
Czer, Lawrence
Shah, Prediman K.
[J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2011, 11 (03) : 153 - 171
[8] Establishing the optimum use of high-intensity interval training in heart failure: current status and future directions
Moneghetti, Kegan
Carrick-Ranson, Graeme
Howden, Erin J.
[J]. CURRENT OPINION IN PHYSIOLOGY, 2023, 34
[9] Current and future status of stem cell therapy in heart failure
D'Alessandro D.A.
Michler R.E.
[J]. Current Treatment Options in Cardiovascular Medicine, 2010, 12 (6) : 614 - 627
[10] CURRENT STATUS UNSOLVED PROBLEMS AND FUTURE DIRECTIONS IN CONGESTIVE HEART FAILURE RESEARCH
WERKO, L
[J]. AMERICAN HEART JOURNAL, 1965, 70 (03) : 402 - &

← 1 2 3 4 5 →